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Romanian Journal of Diabetes Nutrition & Metabolic Diseases / Vol. 24 / no. 3 / 2017 being an extremely costly disorder from a socialeconomic standpoint. The global prevalence of DM is estimated to be around 8.5%, almost 415 million people being diagnosed with this disease. It is estimated that their number will reach 642 million in 2040 [1] .
Patients with DM have significantly higher mortality and morbidity rates compared to the general population, mainly due to the numerous associated chronic complications [2] . Cardiovascular disease (including ischemic heart disease, cerebrovascular disease and peripheral artery disease) is the most severe macrovascular complication found in patients with DM [3] .
More than one third of DM patients develop microangiopathic complications such as retinopathy, nephropathy and neuropathy [4, 5] . Metabolic disorders (hyperglycemia, accumulation of advanced glycation end products, oxidative stress), as well as renal vasoactive factors (renin-angiotensin-aldosterone system and other vasoconstrictors) play a very important role in the occurrence of diabetic nephropathy (DN) [6, 7] . DN, characterized by high blood pressure, proteinuria and alteration of the renal function, is the major cause for end stage chronic kidney disease (ESCKD) [8] [9] [10] [11] .
Lipid metabolism disorders (increase of LDLc particles, fasting and postprandial hypertriglyceridemia, decrease of HDLc and increase of Apo-B) are more frequent in patients with DM and CKD, dyslipidemia being aggravated by the presence of hyperglycemia and IR [12] [13] [14] [15] .
The pathogenesis of dyslipidemia in DM is complex. Insulin mediates the uptake of free fatty acids (FFA) by fatty tissue and skeletal muscle. Thus, IR increases the levels of free FFA released by the liver, determining an increase in the production and concentration of VLDL and the appearance of hypertriglyceridemia. Insulin deficiency and/or IR, present in different degrees in patients with DM contribute to the quantitative and qualitative changes occurring in all lipoprotein (LP) fractions. Hypertriglyceridemia (HTG) is the most frequent pathogenic occurrence. The pathogenetic mechanisms involved in HTG are: the decrease of lipoprotein lipase (LPL) action, which reduces chylomicron and VLDL particles catabolism and lowers the VLDL to LDL conversion rate, the stimulation of adipocyte hormone-sensitive lipase, resulting in an increase in the hepatic influx of FFAs by stimulating the synthesis of VLDL and apo B100, an increase in the activity of cholesteryl ester transfer protein (CETP) which is responsible for the compositional abnormalities encountered in the VLDL particles. Postprandial hyperlipidemia, having both an exogenous and endogenous source, is the result of an imbalance between excessive dietary fat intake (with increased chylomicron generation), on one hand, and increased VLDL synthesis paired with a decrease in LPL activity on the other [16] . The small and dense LDLc particles penetrate the artery wall having a high glycation and oxidation susceptibility which leads to atherosclerosis. IR can also increase the hepatic overproduction of lipoproteins (LP) containing Apo-B, and implicitly lead to the increase of hepatic concentration of VLDLc [17, 18] .
Dyslipidemia is a frequent complication of CKD, thus contributing to the increase of cardiovascular risk (CVR) in these patients. In patients with ESCKD, LDLc and HDLc particles undergo a series of oxidizing processes that generate low density LP and lead to an increase in the oxidized sub-fraction of LDLc. In the case of nephrotic syndrome (NS) the lipid profile is intensely atherogenic, with an increase of total cholesterol (TC), triglycerides (TG), LDLc and lipoprotein A (LPA), as well as a decrease of HDLc [19, 20] .
Dyslipidemia alters the endothelium of the glomerular capillaries and the mesangial cells. The mesangial cells express receptors for both oxidized LDL and LDL, whose activation determines the proliferation of mesangial cells, a thickening of the glomerular basal membrane and the expansion of the mesangium through matrix accumulation, increases the production of chemokines (macrophage chemotactic protein 1 -MCP-1), cytokines (IL-6) and growth factors. MCP-1 increases the macrophage recruitment process. Once infiltrated in the renal glomerulus the macrophages become foam cells that release cytokines. Oxidized LDL increases the adhesion of monocytes to glomerular endothelial cells, thus favorizing the infiltration of monocytes and the affection of tubular epithelial cells. Hypercholesterolemia and hypertriglyceridemia are associated with podocite injury, which, secondarily, causes mesangial sclerosis. Oxidized LDL induces the apoptosis of podocytes and nephron loss (a key component of the glomerular filtering barrier), with an increase of albumin diffusion into the podocyte monolayers [21] [22] [23] [24] .
The main aim of this study was to investigate the correlation between the fractions of the lipidic metabolism and the alteration of the renal function in patients with DM. We have also analyzed the correlations between lipid profile parameters, CKD, glycemic control and the CVR.
Material and method

Study description
This study included 2732 patients with DM which were treated in the Timisoara Center of Diabetes, for a 6-month period from March to October 2016, of which 1508 were women (55.2%) and 1224 were men (44.8%). Mean age was 63.7 ± 9.1 (33-78) years and mean DM duration was 12.4 ± 6.8 (6-33) years. In regard to the types of DM, 312 patients (11.4%) had T1DM and 2420 patients (88.6%) had T2DM.
Studied parameters
The following parameters were evaluated: gender, age (years), weight status: body mass index (BMI) expressed in kg/m 2 , abdominal circumference (AC) expressed in cm. We have also collected data related to family history, alcohol consumption, smoking habits and hypertension (HTN). The quality of the glycemic control was quantified through the value of HbA1c (%).
We have assessed the presences of microvascular, macrovascular and neuropathic complications in all the patients included in the present study. Diabetic retinopathy (DR) was established based on an ophthalmoscopic exam.
The glomerular filtration rate (GFR) was calculated and expressed in ml/min, by using the Modification of Diet in Renal Disease (MDRD) equation. A decrease in GFR < 60 ml/min/1,73m 2 , sets the diagnosis of CKD, regardless of the urinary albumin. The lipid profile was calculated by dosing TC (mg/dl), HDLc (mg/dl) and TG (mg/dl) levels. LDLc (mg/dl) was calculated using the Friedewald formula: TC-(TG/5)-HDLc (mg/dl) when TG levels are lower than 400 mg/dl and measured directly in the case of TG values of over 400 mg/dl.
Statistical analysis
Data was collected and analyzed using SPSS v.17 software suite (SPSS Inc. Chicago, IL, USA) and is presented as mean ± standard deviations (for continuous variables with Gaussian distribution), or percentages (categorical variables). Continuous variable distributions were tested for normality using Shapiro-Wilk test and for equality of variances, with Levene's test.
In order to assess the significance of the differences between groups, t-student (means, Gaussian populations), Mann-Whitney U (notGaussian populations), and chi-square with Yates correction (proportions) tests were used.
A p value <0.05 was considered the threshold for statistical significance.
Results
Prevalence of CKD among the patients in our study was of 12.5% (342 patients). As related to gender, CKD prevalence was higher in women than in men: 231 women (15.3%) vs. 111 men (9.1%) (Figure 1) . Regarding the prevalence of CKD according to the type of DM, we have found that the prevalence of CKD was two times higher in the case of T2DM, compared to T1DM: 13.4%, respectively 5.8%. This may be explained by the longer duration of DM in the case of patients with T2DM. Table 1 shows the main parameters of the patients included in the study, according to gender (Table 1) . Statistically significant differences were observed in the case of all researched parameters, with GFR significantly lower in women (p< 0.0001). Moreover, we have concluded that the mean values of TC and LDLc have been statistically higher in women (Table 1) .
To establish the potential correlations between the lipid profile of the patients included in the study and presence of CKD, we have made a comparison between the main parameters, on value intervals for the GFR (Table 2) . 
Figure 2. Presence of macroangiopathic complications, as related to the GFR value (ml/min).
We have noticed that age, DM duration and the BMI of patients with a GFR value lower than 60 ml/min were significantly higher than those of patients with GFR > 60 ml/min (p<0.0001). Moreover, lipid profile parameters: serum TC, serum TG and serum LDLc were significantly higher in the case of diabetic patients with CKD (p<0.0001).
In order to assess the CVR, we have investigated the presence of macrovascular complications in the patients included in the study: ischemic heart disease (IHD), strokes, as well as the presence of peripheral artery disease (PAD). These complications have been analyzed according to the the GFR values (Figure 2) .
The prevalence of IHD and strokes was almost twice increased in patients with CKD, compared to patients without CKD (Figure 2) . DA was present in 16.9% of patients with CKD and in 11% of those without CKD.
HTN prevalence was of 91.8% in patients with CKD (GFR< 60 ml/min) and of 67.1% in patients without CKD (GFR > 60 ml/min) (Figure 3) . 
Discussions
DN is the main cause of ESCKD. In the same time, patients with T2DM and CKD have a much higher rate of mortality compared to patients without DN.
Numerous studies have revealed the fact that dyslipidemia is a major risk factor for the appearance of CKD. An observational study that included 1428 patients tracked for a period of time between 5 and 6 years, with a GFR > 70 ml/min, has proven that patients with TC values equal to or higher than 350 mg/dl have had a greater decline of the renal function compared to the patients with TC values lower than 250 mg/dl. This fact has been observed both in patients with DM (RR 2.4, 95%CI 1.1-5.2), as well as in patients without DM (RR 4, 95%CI, 1.3-12.5) [25, 26] . More studies that included patients with HTN and an initially normal renal function, have been indicated that systolic blood pressure (SBP) and the mean value of TC are major risk factors in the development of CKD (GFR < 60 ml/min) [27- Overall, there are various and extremely different results related to the association of different types of dyslipidemia and the stages of CKD.
Conclusions
An extremely atherogenic diabetic dyslipidemia is strongly correlated with the appearance and progression of DN, as well as with a high CVR.
The prevalence of IHD and strokes was two times higher in the case of patients with CKD. All the parameters of the lipid profile were statistically significant higher in diabetic patients with CKD.
The decline of the renal function is strongly correlated with age, DM duration and the body weight status of these patients.
To prevent alteration of renal function and delay of these severe complications requires a multifactorial and interdisciplinary approach, a sustained and individualized diet and intensive therapies.
